about-me variable
Seppic invites you to their event

Quality by design in hydrophilic matrices formulation

About this event

Webinar Seppic & Shin Etsu “Quality by design in hydrophilic matrices formulation” 8th June 2021

During this 60-minute webinar, on Tuesday 8th June 2021 from 10.00am to 11.00am, Seppic & Shin Etsu will be delighted to present:

Sustained release dosage form is defined as well characterized and reproducible dosage representing significant advantages used for different therapeutic areas to :

  • Control drug release profile at a specified rate to achieve desired drug concentration either in blood plasma or at target site.
  • Reduce the total amount of administered drug and possible side-effects related to high peak plasma drug levels
  • Improve patient compliance
  • Increase safety of drugs

This form is highly dependent on different parameters. Seppic and Shin-Etsu are happy to present this seminar to address :

  • How Quality by Design can enhance the knowledge space of hydrophilic matrices formulations
  • Understanding the influence of the critical quality attributes of hypromellose
  • How to assess robust formulations
  • Looking into the QbD in case studies

Take a chance to talk with Muriel ROCHE, Seppic Sales Manager, Véronique HENNER-KULKARNI, Shin Etsu Technical Sales Manager and Dr Eric SERRIS, Les Mines Saint-Etienne Research engineer in the department of natural and industrial processes (SPIN) to find out more. Register today!




Hosted by

  • Team member
    T
    Eric Serris

  • Team member
    T
    Véronique Henner-Kulkarni

Seppic

Ingredients that inspire

An Air Liquide Healthcare company, subsidiary of the Air Liquide group, Seppic has been designing, manufacturing, and marketing unique ingredients for over 75 years. These ingredients are used by consumers, patients, and professionals.
Worldwide, a vast team of talented women and men serve customers